RCC is relatively rare; but indications for post operative XRT vary from "positive margins", to capsular invasion and nodal metastasis. While I was reading about it, I was struck that much of the "evidence" comes in from retrospective studies and few poorly designed prospective studies where loco-regional recurrence rates was not the end point of the study design. In addition to that, there have been few number of patients and literature quotes that this is "radio-resistant" tumor (http://www.ncbi.nlm.nih.gov/pubmed/12118559?dopt=Abstract).
I am linking to meta-analysis published in recent issue of Annals of Oncology here: http://www.scribd.com/doc/37912346/Need-for-a-New-Trial-to-Evaluate-Postoperative-Radiotherapy-in-Renal-Cell-Carcinoma-a-Meta-Analysis-of-Randomized-Controlled-Trials. Please feel free to download it. (PMID: 20139152).
At the same time, it led me to think that since this is "radio-resistant" tumor, can hypofractionation (with conformal techniques) be really helpful?
A Pubmed search lead me to following articles:
http://www.scribd.com/doc/37912667/Do-Patients-Receiving-Whole-Brain-Radiotherapy-for-Brain-Metastases-From-Renal-Cell-Carcinoma-Benefit-From-Escalation-of-the-Radiation-Dose
What is the opinion of the forum to push for Radiation in Renal Cell Carcinoma? It's time that overt reliance on targeted therapy be discarded in favor or perhaps stereotactic/ conformal hypofractionated regimens and/or under the ambit of a well designed prospective clinical trial.
@Santam: Am on Linux Mint (9) now and realized that Ubuntu's installer is best in Linux world at present. Maybe perhaps in near future (when I have better bandwidth), I'd shift to a rolling release distro; most likely debian only.
Reality is merely a persistent illusion